Research reference
Esculentin-1
Published sources available; full evidence profile in development.
4 published source records. Source publication does not imply scientific appraisal.
Open sources for Esculentin-1 →Peptide directory
Find a peptide
Public profiles inside a larger governed registry
Search by peptide name, brand, or research code. Open a full evidence profile or the published sources available for a record still in development. Source publication does not mean a completed scientific appraisal.
The registry is an expanding catalog, not a complete list of every peptide. A missing public result does not mean no research exists.
Published profiles
Search profiles and sources
Synthetic peptide
Etelcalcetide
Published sources available; full evidence profile in development.
6 published source records. Source publication does not imply scientific appraisal.
Open sources for Etelcalcetide →Research reference
Evasin-3
Published sources available; full evidence profile in development.
4 published source records. Source publication does not imply scientific appraisal.
Open sources for Evasin-3 →Synthetic dipeptide
EW peptide
Published sources available; full evidence profile in development.
2 published source records. Source publication does not imply scientific appraisal.
Open sources for EW peptide →- Emerging
Exenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist. WPF organizes its research by formulation, type 2 diabetes outcomes, comparative studies, safety and tolerability, and other investigated questions. Formulation and dosing schedules differ across studies, so results from one preparation or population should not automatically be generalized to another.
Evidence and record details
Evidence integrity map
Human 0Preclinical 0Durable IDs 6Open signals 1- Publication state
- Published profile
- Verified source records
- 5 source records verified
- Chemistry record
- No governed record published
- Regulatory entries
- No published regulatory entry on file
- Research questions
- No open questions documented
- Evidence review date
- No documented human review recorded
Source verification checks records; it does not itself approve scientific conclusions.
Bioactive peptide
Exendin-3
Published sources available; full evidence profile in development.
2 published source records. Source publication does not imply scientific appraisal.
Open sources for Exendin-3 →GLP-1 receptor agonist peptide
Exendin-4
Published sources available; full evidence profile in development.
3 published source records. Source publication does not imply scientific appraisal.
Open sources for Exendin-4 →GLP-1 receptor antagonist peptide fragment
Exendin-9-39
Published sources available; full evidence profile in development.
2 published source records. Source publication does not imply scientific appraisal.
Open sources for Exendin-9-39 →GnRH analog
Fertirelin
Published sources available; full evidence profile in development.
4 published source records. Source publication does not imply scientific appraisal.
Open sources for Fertirelin →Endogenous glycoprotein
Follistatin
Published sources available; full evidence profile in development.
3 published source records. Source publication does not imply scientific appraisal.
Open sources for Follistatin →D-retro-inverso research peptide
FOXO4-DRI
Published sources available; full evidence profile in development.
1 published source records. Source publication does not imply scientific appraisal.
Open sources for FOXO4-DRI →Endogenous neuropeptide
Galanin
Published sources available; full evidence profile in development.
4 published source records. Source publication does not imply scientific appraisal.
Open sources for Galanin →Endogenous neuropeptide
Galanin-like peptide
Published sources available; full evidence profile in development.
3 published source records. Source publication does not imply scientific appraisal.
Open sources for Galanin-like peptide →GnRH antagonist salt/reference
Ganirelix acetate
Published sources available; full evidence profile in development.
4 published source records. Source publication does not imply scientific appraisal.
Open sources for Ganirelix acetate →Endogenous gastrointestinal peptide hormone
Gastrin
Published sources available; full evidence profile in development.
1 published source records. Source publication does not imply scientific appraisal.
Open sources for Gastrin →Gastrin peptide form
Gastrin-17
Published sources available; full evidence profile in development.
2 published source records. Source publication does not imply scientific appraisal.
Open sources for Gastrin-17 →Gastrin peptide form
Gastrin-34
Published sources available; full evidence profile in development.
3 published source records. Source publication does not imply scientific appraisal.
Open sources for Gastrin-34 →Endogenous regulatory peptide
Gastrin-releasing peptide
Published sources available; full evidence profile in development.
3 published source records. Source publication does not imply scientific appraisal.
Open sources for Gastrin-releasing peptide →
How the public directory relates to the 500-record Master Registry
master registry transparency
500 master records, with governance status shown explicitly
501
Master records
467
Governed records
34
Review-deferred
458
Peptide acquisition eligible
9
Governed comparators
The master registry has 467 governed identities from 501 records. 34 remain review-gated. Nine governed records are scientific comparators, leaving 458 peptide identities in the source acquisition cohort. Database reconciliation is a separate step. The 51 profiles shown on this directory are a represented public-profile subset, not the size of the master registry. All 51 public profiles on this render reconcile to governed peptide identities in that registry; unknown, duplicate, deferred, or comparator identities fail closed instead of appearing publicly.
Explore the full Master Registry →What the profile status labels mean
Evidence, chemistry, and regulatory counts include only records that crossed the relevant public-publication gate. A zero means none published in that lane—not that nothing is known. “No governed record published” is a publication-state disclosure; internal or pending material may exist without appearing in public counts. Source verification, editorial publication, and accountable scientific appraisal are distinct states; a source count alone does not approve a scientific conclusion.
Recently updated public records
When each public profile record was last changed — not clinical or scientific activity.